September 11, 2024
2
Min
PanTera Secures €93mn to Ramp Up Production of World's Rarest Cancer Treatment
PanTera, a joint venture between IBA and SCK CEN, has raised €93 million in an oversubscribed Series A funding round to boost production of actinium-225, a rare radioisotope seen as a breakthrough in cancer treatment. The funds will go toward building a high-tech facility in Mol, Belgium, capable of producing enough actinium-225 to treat over 100,000 patients annually.